While still in an early stage, interest in testing asymptomatic patients is growing as drug developers explore treating Alzheimer's at earlier points in the disease.

The panel is for use with Randox's Evidence MultiSTAT analyzer, which is also FDA cleared, and provides the simultaneous detection of 15 drugs of abuse — including methamphetamine, fentanyl, marijuana ...

The platform uses impedance flow cytometry to measure the electrical properties of bacteria that have been plated from a positive blood culture sample.

The test integrates the measurements of five proteins to assess if patients have the brain pathology characteristic of Alzheimer's disease.

The bill delays PAMA price cuts until Jan. 1, 2027 and updates the data collection period to be used to establish 2027 lab rates from 2019 to 2025.

The agency said that impurities in the company's Safe-T-Fill EDTA tubes may be related to false positive lead testing results reported by users of Magellan Diagnostics' lead detection tests.

The 15-minute test runs on the Diasorin Liaison Nes system and obviates the need for molecular confirmation of negative rapid immunoassay results.

NEW YORK – T2 Biosystems said on Tuesday that it will immediately wind down its operations and liquidate the company.

The coalition will invest the money in six collaborative research projects focused on pancreatic, ovarian, and esophageal cancers, as well as cancer predisposition syndromes.

The newly formed coalition aims to increase access to noninvasive diagnostics for metabolic dysfunction-associated steatotic liver disease (MASLD).

Last week, readers were most interested in a story about whether labs who want FDA authorization of their LDTs can send the tests to the agency for review.

While labs overwhelmingly welcomed the ruling, it could make it more difficult for firms that want FDA's imprimatur for LDTs ...